Tumor-induced thymic atrophy

Alteration in interferons and Jak/Stats signaling pathways

Roberto Carrio, Marta Torroella-Kouri, Vijaya Iragavarapu-Charyulu, Diana M Lopez

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The thymus is the major site of T cell differentiation and a key organ of the immune system. Thym atrophy has been observed in several model systems including aging, and tumor development. Previous results from our laboratory have reported that the thymic atrophy seen in mammary tumor bearers is associated with a severe depletion of CD4+CD8+ double positive immature cells and changes in the levels of cytokines expressed in the thymus microenvironment. Cytokines regulate numerous aspects of hematopoiesis via activation of the Jak/Stat pathways. In the present study we have used our mammary tumor model to investigate whether changes in the levels of cytokines in the thymus could affect the normal expression of the aforementioned pathways. RNA and protein analysis revealed an overexpression of the different members of interferons, a downregulation of most of the Jak/Stat pathways, and an increased expression of several suppressors of cytokine signaling (SOSC) in the thymuses of tumor bearers. Together, our data suggest that the impaired Jak/Stat signaling pathways observed in the whole thymus of tumor-bearing mice could be contributing to the abnormal T cell development and apoptosis observed during the tumor-induced thymic atrophy.

Original languageEnglish
Pages (from-to)547-553
Number of pages7
JournalInternational Journal of Oncology
Volume38
Issue number2
DOIs
StatePublished - Feb 1 2011

Fingerprint

Thymus Neoplasms
Interferons
Atrophy
Thymus Gland
Cytokines
Breast Neoplasms
T-Lymphocytes
Hematopoiesis
Cell Differentiation
Immune System
Down-Regulation
RNA
Apoptosis
Neoplasms
Proteins

Keywords

  • Interferons
  • Jak/Stat pathways
  • Thymus atrophy
  • Tumor-bearing mice

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumor-induced thymic atrophy : Alteration in interferons and Jak/Stats signaling pathways. / Carrio, Roberto; Torroella-Kouri, Marta; Iragavarapu-Charyulu, Vijaya; Lopez, Diana M.

In: International Journal of Oncology, Vol. 38, No. 2, 01.02.2011, p. 547-553.

Research output: Contribution to journalArticle

Carrio, Roberto ; Torroella-Kouri, Marta ; Iragavarapu-Charyulu, Vijaya ; Lopez, Diana M. / Tumor-induced thymic atrophy : Alteration in interferons and Jak/Stats signaling pathways. In: International Journal of Oncology. 2011 ; Vol. 38, No. 2. pp. 547-553.
@article{86db2c740cba48f4b2364557db57af64,
title = "Tumor-induced thymic atrophy: Alteration in interferons and Jak/Stats signaling pathways",
abstract = "The thymus is the major site of T cell differentiation and a key organ of the immune system. Thym atrophy has been observed in several model systems including aging, and tumor development. Previous results from our laboratory have reported that the thymic atrophy seen in mammary tumor bearers is associated with a severe depletion of CD4+CD8+ double positive immature cells and changes in the levels of cytokines expressed in the thymus microenvironment. Cytokines regulate numerous aspects of hematopoiesis via activation of the Jak/Stat pathways. In the present study we have used our mammary tumor model to investigate whether changes in the levels of cytokines in the thymus could affect the normal expression of the aforementioned pathways. RNA and protein analysis revealed an overexpression of the different members of interferons, a downregulation of most of the Jak/Stat pathways, and an increased expression of several suppressors of cytokine signaling (SOSC) in the thymuses of tumor bearers. Together, our data suggest that the impaired Jak/Stat signaling pathways observed in the whole thymus of tumor-bearing mice could be contributing to the abnormal T cell development and apoptosis observed during the tumor-induced thymic atrophy.",
keywords = "Interferons, Jak/Stat pathways, Thymus atrophy, Tumor-bearing mice",
author = "Roberto Carrio and Marta Torroella-Kouri and Vijaya Iragavarapu-Charyulu and Lopez, {Diana M}",
year = "2011",
month = "2",
day = "1",
doi = "10.3892/ijo.2010.870",
language = "English",
volume = "38",
pages = "547--553",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Tumor-induced thymic atrophy

T2 - Alteration in interferons and Jak/Stats signaling pathways

AU - Carrio, Roberto

AU - Torroella-Kouri, Marta

AU - Iragavarapu-Charyulu, Vijaya

AU - Lopez, Diana M

PY - 2011/2/1

Y1 - 2011/2/1

N2 - The thymus is the major site of T cell differentiation and a key organ of the immune system. Thym atrophy has been observed in several model systems including aging, and tumor development. Previous results from our laboratory have reported that the thymic atrophy seen in mammary tumor bearers is associated with a severe depletion of CD4+CD8+ double positive immature cells and changes in the levels of cytokines expressed in the thymus microenvironment. Cytokines regulate numerous aspects of hematopoiesis via activation of the Jak/Stat pathways. In the present study we have used our mammary tumor model to investigate whether changes in the levels of cytokines in the thymus could affect the normal expression of the aforementioned pathways. RNA and protein analysis revealed an overexpression of the different members of interferons, a downregulation of most of the Jak/Stat pathways, and an increased expression of several suppressors of cytokine signaling (SOSC) in the thymuses of tumor bearers. Together, our data suggest that the impaired Jak/Stat signaling pathways observed in the whole thymus of tumor-bearing mice could be contributing to the abnormal T cell development and apoptosis observed during the tumor-induced thymic atrophy.

AB - The thymus is the major site of T cell differentiation and a key organ of the immune system. Thym atrophy has been observed in several model systems including aging, and tumor development. Previous results from our laboratory have reported that the thymic atrophy seen in mammary tumor bearers is associated with a severe depletion of CD4+CD8+ double positive immature cells and changes in the levels of cytokines expressed in the thymus microenvironment. Cytokines regulate numerous aspects of hematopoiesis via activation of the Jak/Stat pathways. In the present study we have used our mammary tumor model to investigate whether changes in the levels of cytokines in the thymus could affect the normal expression of the aforementioned pathways. RNA and protein analysis revealed an overexpression of the different members of interferons, a downregulation of most of the Jak/Stat pathways, and an increased expression of several suppressors of cytokine signaling (SOSC) in the thymuses of tumor bearers. Together, our data suggest that the impaired Jak/Stat signaling pathways observed in the whole thymus of tumor-bearing mice could be contributing to the abnormal T cell development and apoptosis observed during the tumor-induced thymic atrophy.

KW - Interferons

KW - Jak/Stat pathways

KW - Thymus atrophy

KW - Tumor-bearing mice

UR - http://www.scopus.com/inward/record.url?scp=78651230633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651230633&partnerID=8YFLogxK

U2 - 10.3892/ijo.2010.870

DO - 10.3892/ijo.2010.870

M3 - Article

VL - 38

SP - 547

EP - 553

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 2

ER -